Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina's next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 ...
With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...
"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...
On July 31, 2025, the Department of Justice (DOJ) announced a $9.8 million settlement with Illumina Inc., a leading manufacturer of DNA sequencing systems, to resolve potential False Claims Act (FCA) ...
SAN DIEGO, May 28, 2024 /PRNewswire/ -- Illumina Inc. (ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) ...
SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best ...
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 26, 2026 ...
Illumina Inc. was hit with an antitrust lawsuit on Sept. 22 in California Northern District Court over alleged anticompetitive practices in the DNA sequencing market. The action, brought by Quinn ...
Illumina will sequence up to 4,000 unique individual animals across 1,300 species, unlock genomic insights from 50-year-old biological samples Sequencing connects decades of preserved biodiversity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results